Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00682682 · ClinicalTrials.gov registry record · NA

Reducing Brief Thermal and Electrical Pain (Four Study Days)

A NA study of Pain, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT00682682: Completed NA study of Pain, sponsored by University of Washington.

NCT00682682 is a NA study of Pain that has completed, run by University of Washington. The registered enrollment target is 20 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00682682, a NA study of Pain, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

Ultimately, the purpose of the present study is to help improve pain control in burn patients during wound care and physical therapy, where pain levels with opioids alone are often excessively high. This study measures how much virtual reality pain distraction reduces pain compared to traditional opioid pain meds, and whether there is additional pain reduction when Virtual Reality distraction + Opioids are combined. In addition to studying the amount of pain reduction, this study will also measure side effects (if any) of the two treatments (Virtual Reality pain distraction and Opioids) alone and when combined. Healthy volunteers will be recruited from advertisements will undergo a trial of the pain testing. They will receive a series of brief stimuli (at a painful but tolerable safe intensities they select and approve during baseline testing), separated by intervals of no pain. Participants will rate how much pain they felt after each brief stimulus, and will fill out side effects questionnaires after finishing the pain session. Subjects will participate in each of the four conditions in which the order is randomized. * No opioids (0ng/ml hydromorphone) + no virtual reality Snow World distraction * No opioids + yes virtual reality Snow World distraction * Moderate dose of pain medicine (4ng/ml hydromorphone) + no virtual reality * Moderate dose of pain medicine + yes virtual reality Snow World distraction It is our hypothesis that VR distraction + opioids will show a reduced perception of pain in subjects more than opioids alone or no intervention (control).

Conditions Studied

Interventions

  • OTHER Virtual Reality video distraction
  • OTHER Virtual Reality video game

Study Locations (1)

Washington

  • University of Washington - Seattle

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2007-12
Est. Completion 2008-12
Phase NA
University of Washington

1,048 total trials

What the finished NCT00682682 record still lists

NCT00682682 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 304-participant average among 374 other Pain trials with a reported enrollment target (93% lower).

The record links to 1 condition, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Virtual Reality video distraction is the first listed.

NCT00682682 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00682682 about?

NCT00682682 is a clinical study titled "Reducing Brief Thermal and Electrical Pain (Four Study Days)". Ultimately, the purpose of the present study is to help improve pain control in burn patients during wound care and physical therapy, where pain levels with opioids alone are often excessively high. This study measures how much virtual reality pain distraction reduces pain compared to traditional o...

What is the current status of trial NCT00682682?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2007-12. Estimated completion is 2008-12.

What conditions does trial NCT00682682 study?

This clinical trial studies the following conditions: Pain.

What interventions are being tested in trial NCT00682682?

The interventions under investigation include: Virtual Reality video distraction (OTHER), Virtual Reality video game (OTHER).

Who is sponsoring clinical trial NCT00682682?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00682682 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00682682's enrollment target sits among peer trials

20 338th of 374 higher than 29 of 374 other Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00682682, the US trial registry maintained by the National Library of Medicine. NCT00682682 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.